10Q | NAVB Message Board Posts


Navidea Biopharmaceuticals, Inc.

  NAVB website

NAVB   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  37770 of 38282  at  8/15/2022 5:06:39 PM  by

FIRAC


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 3  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
37771 Re: 10Q--was full $1.5mm loan (B.Sheet adjusted to $720k for accounting amortization), plus partner source of reimbursement moneyonomics 2 8/15/2022 5:17:05 PM
37772 Re: 10Q--pre view of RA P3 progress: third party expenditures on Diagnostics development down 8% ytd from 2021..therapeutics flat moneyonomics 2 8/15/2022 5:28:18 PM




Financial Market Data provided by
.
Loading...